The Sub-fund aims to outperform (after deduction of costs) the MSCI ACWI Index, as stated in sterling, by at least 2.5% per annum over rolling five-year periods. The Sub-fund will invest at least 90% in shares of companies that have the potential to deliver substantial improvements to human health, lengthen lifespans and reduce healthcare costs. The companies that the Sub-fund invests in will bring innovation to human health through increasing understanding and detection of disease, and by improving treatments, devices and operational efficiencies. The Sub-fund will be actively managed and will invest in companies in any country and of any size.
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 今天的股價是多少?▼
GB00BMVLY145.FUND 目前價格為 £0.57 GBP,過去 24 小時下跌了 -1.81%。在圖表上更密切關注 Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 股票的表現。
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Funds 交易所,Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 的股票以代號 GB00BMVLY145.FUND 進行交易。
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 位於哪個產業?▼
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP從事於Other產業。
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 何時完成拆股?▼
Baillie Gifford Investment Funds II ICVC-Baillie Gifford Health Innovation Fund B GBP 最近沒有進行任何拆股。